Non-homologous dsODN increases the mutagenic effects of CRISPR-Cas9 to disrupt oncogene E7 in HPV positive cells.
Fan W, Yu M, Wang X, Xie W, Tian R, Cui Z, Jin Z, Huang Z, Das BC, Severinov K, Hitzeroth II, Debata PR, Tian X, Xie H, Lang B, Tan J, Xu H, Hu Z.
Fan W, et al. Among authors: tan j.
Cancer Gene Ther. 2022 Jun;29(6):758-769. doi: 10.1038/s41417-021-00355-z. Epub 2021 Jun 10.
Cancer Gene Ther. 2022.
PMID: 34112918